Department of Orthopedics, Hualien Armed Forces General Hospital, Hualien, 971, Taiwan, ROC.
Department of Life Science and the Institute of Biotechnology, National Dong Hwa University, Hualien, 974, Taiwan, ROC.
BMC Geriatr. 2022 Feb 23;22(1):150. doi: 10.1186/s12877-022-02832-y.
This study aimed to evaluate the impact of chronic liver disease and cirrhosis on inpatient outcomes of geriatric hip fracture surgery.
Using population-based retrospective study design, this study extracted data from the US Nationwide Inpatient Sample (NIS) database 2005-2014, identifying patients aged ≥ 65 years undergoing hip fracture repair. Main outcomes were in-hospital mortality, any/specific complications, non-routine discharge, extended length of stay (LOS) and hospital costs. Associations between cirrhosis, non-cirrhotic chronic liver disease and outcomes were determined using regression analysis.
Data of 347,363 hip fracture patients included 344,035 without liver disease, 1257 with non-cirrhotic chronic liver disease and 2,071 with cirrhosis. After adjustments, non-cirrhotic chronic liver disease was significantly associated with non-routine discharge (OR: 1.247, 95% CI: 1.038-1.498), acute kidney injury (OR: 1.266, 95% CI: 1.039-1.541), extended LOS (OR: 1.285, 95% CI: 1.122-1.473) and hospital costs (beta: 9173.42, 95% CI: 6925.9-11,420.95) compared to no liver disease; while cirrhosis was significantly associated with higher risk of in-hospital mortality (OR: 2.325, 95% CI: 1.849-2.922), any complication (OR: 1.295, 95% CI: 1.143-1.467), acute kidney injury (OR: 1.242, 95% CI: 1.177-1.433), non-routine discharge (OR: 1.650, 95% CI: 1.412-1.928), extended LOS (OR: 1.405, 95% CI: 1.263-1.562) and hospital costs (beta: 6680.24, 95% CI: 4921.53-8438.95) compared to no liver disease.
In geriatric hip fracture patients undergoing surgical repair, non-cirrhotic chronic liver disease and cirrhosis independently predict non-routine discharge, acute kidney injury, prolonged LOS and greater hospital costs, and cirrhosis is also significantly associated with greater risk of any complication and in-hospital mortality.
本研究旨在评估慢性肝病和肝硬化对老年髋部骨折手术住院患者结局的影响。
本研究采用基于人群的回顾性研究设计,从美国全国住院患者样本(NIS)数据库中提取了 2005-2014 年年龄≥65 岁接受髋部骨折修复的患者数据。主要结局为院内死亡率、任何/特定并发症、非常规出院、延长住院时间(LOS)和住院费用。使用回归分析确定肝硬化、非肝硬化慢性肝病与结局之间的关系。
347363 例髋部骨折患者中,344035 例无肝病,1257 例患有非肝硬化慢性肝病,2071 例患有肝硬化。调整后,非肝硬化慢性肝病与非常规出院(OR:1.247,95%CI:1.038-1.498)、急性肾损伤(OR:1.266,95%CI:1.039-1.541)、延长 LOS(OR:1.285,95%CI:1.122-1.473)和住院费用(β:9173.42,95%CI:6925.9-11420.95)显著相关,而非肝硬化慢性肝病与无肝病相比;而肝硬化与院内死亡率(OR:2.325,95%CI:1.849-2.922)、任何并发症(OR:1.295,95%CI:1.143-1.467)、急性肾损伤(OR:1.242,95%CI:1.177-1.433)、非常规出院(OR:1.650,95%CI:1.412-1.928)、延长 LOS(OR:1.405,95%CI:1.263-1.562)和住院费用(β:6680.24,95%CI:4921.53-8438.95)显著相关。
在接受手术修复的老年髋部骨折患者中,非肝硬化慢性肝病和肝硬化独立预测非常规出院、急性肾损伤、延长 LOS 和增加住院费用,而肝硬化也与任何并发症和院内死亡率增加显著相关。